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Figure S1. Generation of MOs with distinct combinations of dual SMAD inhibitors.  
(A and B) Representative morphology of EBs on day 7 of differentiation (A) and MOs after 1WM (B). Scale 
bar, 500 µm.  
(C) Number and quality of MOs (1WM) generated from distinct combinations of dual SMAD inhibitors. Data 
are presented as mean ± SD from three independent experiments. Scale bar, 500 µm.  
(D) Average diameter of NS-, DA-, LS-, and DS-MOs was measured in a time-course manner. Data are 
presented as mean ± SD of triplicate values.  
(E) Representative section image of whole mount confocal microscopy displaying distribution of mDA neurons 
expressing TH in NS-, DA-, LS-, and DS-MOs. Scale bar, 200 µm.  
(F) Heatmap representing the global gene expression profile of day-7 EBs generated with distinct combinations 
of dual SMAD inhibitors. The red-blue color scale is the normalized expression value, denoted as the row Z-
score. Red and blue colors indicate increased expression and decreased expression, respectively. Differentially 
expressed genes among each sample are categorized into four groups (class 1 to 4).  







Figure S2. Midbrain-specific regional identity of DA-MOs 
(A) Confocal images showing distribution of midbrain specific progenitors expressing both LMX1A in MOs 
grown under distinct conditions (NS-, DA-, and LS-MOs) after 4WM. Scale bar, 200 µm.  
(B) Percentage of LMX1A-positive midbrain specific progenitors. Data are presented as mean ± SD from 
three independent experiments. n = 6–8 organoids per group; **p < 0.01. 
(C) Confocal images showing distribution of mDA neuronal progenitors expressing both LMX1A in MOs 
grown under distinct conditions (NS-, DA-, and LS-MOs) after 4WM. Scale bar, 50 µm.  
(D) Percentage of LMX1A-positive mDA neuronal progenitors. Data are presented as mean ± SD from three 




Figure S3. Generation of homogeneous MOs using an in vitro WNT gradient.  
(A and B) Representative morphology (A) and average diameter (B) of MOs generated by an in vitro WNT 
gradient (1WM). Data are presented as mean ± SD of triplicate values. Scale bar, 500 µm.  
(C) Expression of pro-apoptotic genes was analyzed by qPCR using MOs generated by the in vitro WNT 
gradient (1WM). Expression levels are normalized to those of MOs with 0 µM CHIR99021. Data are presented 
as mean ± SD of triplicate values.  
(D) GO enrichment analysis based on the gene set highly enriched in classes 2, 3, and 4, which are categorized 
in Fig 3B.  
(E) Representative section images of whole mount confocal microscopy displaying the distribution of TH-
positive mDA neurons in DA-MOs (3WM) with higher concentrations of CHIR99021 (5 and 10 µM). Scale bar, 
200 µm.  
(F and G) Expression of forebrain- (F) and spinal cord–specific markers (G) was analyzed by qPCR using DA-
MOs produced by the in vitro WNT gradient (3WM). Expression levels are normalized to those of MOs with 0 




Figure S4. Characterization of DAC3.0 MOs.  
(A) 3D reconstructed confocal images showing laminated structure of DAC3.0 MOs (4WM). Scale bar, 50 µm.  
(B) Heatmap displaying the global gene expression profile of DAC3.0 MOs (3WM and 8WM). The red-blue 
color scale is the normalized expression value, denoted as the row Z-score. Red and blue colors indicate 
increased expression and decreased expression, respectively. Differentially expressed genes among each sample 
are categorized into six groups (class 1 to 6).  
(C) GO enrichment analysis based on the gene set highly enriched in each group (class 1 to 6).  
(D) Representative images of single neural lobe immunostained with SOX2, TH, FOXG1, and TBR1 in DAC3.0 
MOs (4WM). Scale bar, 100 µm.  
(E) Confocal images displaying mDA neurons expressing FOXA2, NURR1, GIRK2, and Calbindin in DAC3.0 
MOs (8WM). Scale bar, 50 µm. 
(F and G) Ion channel activity (F) and spontaneous synaptic activity (G) were recorded in DAC3.0 MOs (8WM). 
(H) TEM images displaying neuromelanin-like granules in mDA neurons (arrows) and glycogen granules in 
astrocytes (arrowheads) contained within DAC3.0 MOs (12WM). Scale bar, 2 µm.  
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Figure S5. Cell type diversity in DAC3.0 MOs.  
(A and B) Confocal images representing the distribution of TH-positive mDA neurons and GAD67-positive 
GABAergic neurons in NSC0.8 MOs (A) and DAC0 MOs (B) (8WM). Scale Bar, 100 µm.  
(C) Confocal images displaying GABA-positive GABAergic neurons and GLUT-positive glutamatergic 
neurons in DAC3.0 MOs (8WM). Scale bar, 50 µm.  
(D) Heatmap representing the expression patterns of markers related to neurons in DAC3.0 MOs (3WM, 8WM, 
and 20WM). Color bar at the left top indicates gene expression in log2 scale. Red and green colors represent 
higher and lower expression levels, respectively.  
(E) Heatmap displaying the global gene expression profile of DAC3.0 MOs (3WM, 8WM, and 20WM). The 
red-blue color scale is the normalized expression value, denoted as the row Z-score. Red and blue colors indicate 
increased expression and decreased expression, respectively. Differentially expressed genes among each sample 
are categorized into four groups (class 1 to 4).  
(F) Distribution of cell type–specific marker genes (oligodendrocyte-, astrocyte-, and neuron-specific genes) in 




Figure S6. Gliogenesis in DAC3.0 MOs.  
(A and B) Expression of functional markers of astrocytes (A) and oligodendrocytes (B) in DAC3.0 MOs 
(12WM). Scale bar, 25 µm.  
(C) 3D reconstructed Z-stacks showing direct connection between GFAP-positive astrocytes and TH-positive 
DA neurons. Scale bar, 50 µm.  
(D) TEM images displaying glycogen granule-containing (arrows) astrocytes surrounding neuronal axon (Ax) 
(left panel) and glial filament-like structure (right panel). Scale bar, 2 µm.  
(E) 3D reconstructed Z-stacks displaying direct connection between MBP-positive oligodendrocytes and TH-
positive DA neurons. Scale bar, 50 µm.  
(F) TEM images showing global distribution of myelinating oligodendrocytes (arrows) in DAC3.0 MOs (left 
panel). Oligodendrocyte-like cell body (right panel) containing a dark nucleus with clumped chromatin and 
myelin-like inclusions (arrow heads). Scale bar, 2 µm. 
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Figure S7. mDA neuron–specific cell death in MPTP-treated DAC3.0 MOs.  
(A) TUNEL-labeled mDA neurons in MPTP-treated DAC3.0 MOs (0, 10, 50, and 100 µM). Scale bar, 25 µm. 
(B) mDA neuron–specific cell death—no cell death of other cell types such as GABAergic neurons (GABA), 
astrocytes (AQP4), and oligodendrocytes (PLP)—in MPTP-treated DAC3.0 MOs. Scale bar, 25 µm.  
Supplementary Table 
Supplementary Table 1. Primers used for qPCR 
Gene Name Genebank Number Primer sequence 
NANOG AB093576.1 TGCAACCTGAAGACGTGTGA CTATGAGGGATGGGAGGA 
OCT4 BC117435.1 GACAGGGGGAGGGGAGGAGCTAGG CTTCCCTCCAACCAGTTGCCCCAAAC 
SOX2 BC013923.2 AGACTGCACATGAGCCAGCA CGTCTCCAGCCAGCTTCAAC 
N-CAD AF006514.1 TGATGAAGAAGGTGGAGGAGAAGA ATTCGTCGGATTCCCACAGG 
OTX2 AB593058.1 CCCTCACTCGCCACATCTAC GTTCAGAGTCCTTGGTGGGT 
PLZF NM_006006.5 TCCCGCCCGACTGGAGGATA TTCTTTCCTGGCTCCCCGCTC 
EOMES AB031038.1 CTCAAAAGGCATGGGAGGGTA CACCACCAAGTCCATCTGCAA 
SOX17 AB073988.1 CCTTAGCTCCAGGAAGTGTG GCCAGCTCCGCGGTATATTACT 
T BC098425.1 CGCCTCATAGCCTCATGGAC CACTGGCTGCCACGACAAA 
BOK AF089746.1 GCTGGCCACATCTTCTCTGC TGCTGACCACACACTTGAGGAC 
BAX NM_007527 TGCTGACGTGGACACGGACT CCAGCCACCCTGGTCTTGGA 
BAD NM_007522 TCGGAGTCGCCACAGTTCGT GCGCTCTTTGGGCGAGGAAG 
PMAIP1 KU178264.1 GGGAAGAAGGCGCGCAAGAA AGTTTCTGCCGGAAGTTCAGTTTGT 
BCL2L11 NM_138621.5 GCCCAAGAGTTGCGGCGTATT TCTCCACACCAGGCGGACAAT 
BBC3 U82987.1 CGGACGACCTCAACGCACAGTA AAGGGCAGGAGTCCCATGATGA 
FOXG1 BC050072 GCGGGCCAGACCAGTTACTT CCCAGACAGTCCCGTCGTAA 
LHX2 AF124735.1 ACTTCTGTGCCTGGCAACCTG TCTGTTTCCAGGCGAGATCCT 
SIX3 AF049339.1 AACCTCCAGCGACTCGGAAT TTCGGTTTGTTCTGGGGATG 
LRTM1 BC040732.1 CTGCCATGCCCTTCGTGTGT AACACTTGTCCGGGCAGCTG 
DAT NM_001044.5 CGCCACTGGCTCAAGGTGTA CCGGCACGGAAAGGTGTAA 
TH NM_199292.2 CTGAGATTCGGGCCTTCGAC TGCACCTAGCCAATGGCACT 
LMX1B AH006310.2 GGCATCAAGATGGAGGAGCA TGGTGAGGGCTTGCTGACAC 
LMX1A NM_177398.4 AAAGCGCGATCGACACCTC TCCCGGTAGAAGCAGGTGGT 
ASCL1 NM_004316.4 GGTGATCGCACAACCTGCAT GTTCTGAGCGCTTCCCGTTT 
PAX3 NM_181457.3 TTTCCGTTTCGCCTTCACCT ACGATCTTGTGGCGGATGTG 
HOXD10 NM_002148.3 CTAATTCCAGCGTTTGGTGC CTGAGGTCTCCGTGTCCAGT 
HOXC6 CR456954.1 GAATGAGGGAAGACGAGAAAGAG CATAGGCGGTGGAATTGAGG 
HOXC9 AH010088.2 CTCCTAGCGTCCAGGTTTCC CGGGTGATATACCACGGACG 
HOXA1 U10421.1 AAATCAGGAAGCAGACCCAC GTAGCCGTACTCTCCAACTTTC 
HOXB4 AF307160.1 TACCCCTGGATGCGCAAAGTTC TGGTGTTGGGCAACTTGTGG 
Supplementary Video 
Supplementary Video 1. The laminated layer structure of midbrain-like neural lobe in DAC3.0 
MOs  
The video showing three-dimensionally reconstructed layer structure of midbrain-like neural lobe in DAC3.0 
MOs. The white and red color marked TH-positive mDA neurons and SOX2-positive neural progenitor 
respectively. The nucleus was counter-stained with TOPRO-3 (blue color). 
 
Supplementary Methods 
Cell culture  
hESCs were maintained in TeSRTM-E8TM medium (STEMCELL Technologies). For passaging hESCs, 
ReLeSRTM (STEMCELL Technologies) was used according to the manufacturer’s instructions.  
 
Generation of midbrain organoids 
 To generate MOs, hESCs were dissociated into single cells using TrypLETM (Gibco), and 1.0x104 single cell–
dissociated hESCs were replated per well in ultra low–attachment U-bottom 96-well plates (Corning) for the 
generation of uniform EBs using embryoid body forming medium (EBM), consisting of DMEM/F12 (Corning) 
supplemented with 20% KSR (Gibco), 1% penicillin/streptomycin (PS) (Gibco), GlutaMAXTM (Gibco), NEAA 
(Gibco), 55 µM ß-mercaptoethanol (Gibco), 1 µg/ml of heparin (Sigma), 3% fetal bovine serum (FBS) 
(Seradigm), 4 ng/ml of bFGF (Peprotech), and 50 µM Y27632 (Calbiochem). At 24 hrs after plating, the medium 
was changed to brain organoid generation medium (BGM) containing of 1:1 mix of DMEM/F12 (Corning) and 
Neurobasal Medium (Gibco) supplemented with 100x N2 supplement (Gibco), 50x B27 without vitamin A 
(Gibco), 1% penicillin/streptomycin (PS) (Gibco), 1% GlutaMAXTM (Gibco), 1% NEAA (Gibco), 55 µM ß-
mercaptoethanol (Gibco), and 1 µg/ml heparin (Sigma). For mesencephalon specification, distinct combinations 
of dual SMAD inhibitors employed in previous studies were used: 200 ng/ml Noggin (Peprotech) + 10 µM 
SB431542 (Peprotech) 1; 2 µM dorsomorphin (Sigma) + 2 µM A83-01 (Peprotech) 2; 100 nM LDN (Biogems) 
+ 10 µM SB431542 (Peprotech) 2; and 10 µM dorsomorphin (Sigma) + 10 µM SB431542 (Peprotech) 3. To 
create an in vitro WNT gradient, different concentrations of CHIR99021 (0, 0.8, 1.5, 2, 2.5, 3, 5, and 10 µM) 
(Tocris) were used in the presence of 1 µM IWP2 (Biogems). On day 4, 100 ng/ml FGF8 (Peprotech) and 2 µM 
SAG (Peprotech) were added to induce specification into the mesencephalic floor plate. After 3 days, MOs were 
embedded into growth factor–reduced matrigel (Corning) droplets. Matrigel-embedded MOs were transferred 
onto 6-cm petri dishes containing BGM supplemented with 100 ng/ml of FGF8, 2 µM SAG, 200 ng/ml laminin 
(BD science), and 2.5 µg/ml insulin (Thermo) for facilitating basal-apical lamination. After 2 days, MOs were 
transferred into ultra low–attachment 6-well plates (Corning) containing brain organoid maturation medium 
(BMM), consisting of 1:1 mix of DMEM/F12 (Corning) and Neurobasal Medium (Gibco) supplemented with 
100x N2 supplement (Gibco), 50x B27 (Gibco), 1% penicillin/streptomycin (PS) (Gibco), 1% GlutaMAXTM 
(Gibco), 1% NEAA (Gibco), 55 µM ß-mercaptoethanol (Gibco), 1 µg/ml heparin (Sigma), 10 ng/ml BDNF 
(Peprotech), 10 ng/ml GDNF (Peprotech), 200 µM ascorbic acid (Peprotech), and 125 µM cAMP (Peprotech). 
From this maturation step, MOs were cultured on an orbital shaker (Stuart). BMM was replaced every other 
day. For assessing the production of neuromelanin in MOs, 50 µM DA (Sigma) was added to BMM from 8WM 
MOs.  
 
Generation of cerebral organoids 
To generate cerebral organoids (COs), 1x104 single cell–dissociated hESCs were plated on each well of ultra 
low–attachment U-bottom 96-well plates (Corning). At 24hrs after plating, BGM supplemented with 2 µM 
dorsomorphin and 2 µM A83-01 was added to EBs. The medium was replaced every other day. After 7 days of 
differentiation, COs were embedded into growth factor–reduced matrigel (Corning) droplets. Matrigel-
embedded COs were transferred to 6-cm petri dishes containing BGM supplemented with 200 ng/ml laminin 
and 2.5 µg/ml insulin for inducing basal-apical lamination. After 2 days, COs were transferred into ultra low–
attachment 6-well plates (Corning) containing BMM and cultured on an orbital shaker (Stuart). The culture 
medium was replaced every other day. 
 
Gene expression analysis 
For comparing the relative expression levels of marker genes, total RNA was isolated from organoids using the 
Hybrid-RTM RNA isolation kit (GeneAll). Complementary DNA (cDNA) was synthesized with the High 
Capacity cDNA Reverse Transcription kit (Applied biosystems) using 1 µg of isolated total RNA. Quantitative 
RT-PCR (qPCR) was performed with the SYBR green PCR Master Mix (Applied biosystems) using the ABI 
7500 real-time PCR system (Applied biosystems). ΔCt values were calculated by subtracting the Gapdh Ct 
value from that of each target gene. Relative expression levels were calculated by using 2−ΔΔCt methods. Primer 
sequences used for qPCR are listed in supplementary Table S1. 
 
Cryosection 
The organoids were fixed with 4% paraformaldehyde (Sigma) for 15 to 20 min at room temperature and washed 
three times with PBS. The fixed organoids were transferred to 30% sucrose solution and incubated at 4ºC until 
the organoids sank to the bottom. Equilibrated organoids were then transferred to freezing mold containing 1:1 
mixture of OCT compound and 30% sucrose solution and slowly frozen on dry ice. Frozen blocks can be stored 
at -80 ºC for up to 2 months. Frozen blocks containing organoids were sliced with a cryotome. The microsections 
of frozen blocks were attached onto silane-coated glass microslides (Muto pure chemical). Sliced tissue sections 
were air dried.  
  
Immunohistochemistry 
Immunohistochemical analysis was performed on the sectioned organoids. Briefly, the dried tissue sections 
were permeabilized and blocked with DPBS (Welgene) containing 0.03% Triton X-100 (Sigma) and 5% FBS 
(Seradigm) for 1 hr at room temperature. The permeabilized tissue sections were then incubated with the 
appropriate primary antibody for 16 hrs at 4ºC, and then incubated with the appropriate secondary antibody 
after being washed three times with DPBS (Welgene). Counterstaining was performed with TOPRO-3 (Life 
Technology). Primary antibodies used for immunohistochemistry are as follows: MAP2 (Merck millipore), TH 
(Abcam), ASCL1 (BD pharmingen), LMX1A (Santa cruz), TBR1 (Abcam), TUJ1 (Biolegend), SOX2 (R&D 
system), GAD67 (Merck millipore), vGLUT (Merck millipore), FOXA2 (Abcam), LRTM1 (Cusabio), DAT 
(Merck millipore), NURR1 (Santa cruz), GIRK2 (Abcam), CALB (Merck millipore), FOXG1 (Abcam), GABA 
(Sigma), GLUT (Cusabio), GFAP (CiteAb), S100B (Abcam), MBP (Abcam), ALDH1L (Abcam), MAO-B 
(Abcam), AQP4 (Merck millipore), O4 (R&D system), OLIG2 (Merck millipore), PLP1 (Cusabio), and 
Caspase-3 (Cell signaling). 
 
Whole mount immunostaining 
For immunostaining of whole organoids without microsectioning, whole organoids were fixed with 4% 
paraformaldehyde (Sigma) for 15 to 20 min at room temperature and washed three times with PBST containing 
DPBS supplemented with 0.1% Triton X-100. Fixed organoids were transferred into blocking solution 
containing DPBS supplemented with 6% BSA (Sigma), 0.2% Triton X-100, and 0.01% sodium azide 
(Biosolution) and then incubated overnight on rocking platform mixer at room temperature. The samples were 
incubated with primary antibodies for 48 hrs on a rocking platform mixer at room temperature. After washing 
three times with PBST, the organoids were incubated with fluorescence-labeled secondary antibody and 
TOPRO-3 on a rocking platform mixer for 48 hrs at room temperature. After rinsing three times with PBST, 
the immunostained organoids were transferred onto 35-mm glass-bottom dishes (SPL) and immersed into 
clearing solution to adjust the RI value. For whole mount confocal imaging, LSM 710 (Zeiss) was used. 
 
Fontana-Masson staining 
The neuromelanin pigment was stained by the Fontana-Masson Stain Kit (Abcam) according to manufacturer’s 
instructions using cryosectioned organoids. 
 
TEM imaging 
The organoids were pretreated with 0.1 M phosphate buffer (pH 7.4) containing 2% paraformaldehyde and 2.5% 
glutaraldehyde for 16 hrs at 4ºC. The organoids were then fixed with 1% osmium tetroxide for 90 min. The 
fixed organoids were dehydrated by stepwise immersion in 60%, 70%, 80%, and 90% ethanol, for 20 min each 
time. The organoids were completely dehydrated by immersing them three times in 100% ethanol for 90 min 
for each time. The dehydrated organoids were embedded into Epon and allowed to polymerize at 68ºC for 48 
hrs to form a block. The block was sliced into 60-nm thin sections by using a UC6 ultramicrotome (Leica 
microsystems). The section slices were stained with uranyl acetate and lead citrate and observed by the 
transmission electron microscope (TEM) H-7500 (Hitachi). 
 
Electrophysiology 
To examine the electrophysiological properties of organoids, whole cell patch clamp recording was performed 
using a MultiClamp 700B amplifier that was filtered 5 kHz and sampled at 10 kHz. An organoid was placed in 
a chamber and submerged into continuously perfused artificial CSF containing 1 mM NaH2PO4, 26.2 mM 
NaHCO3, 118 mM NaCl, 2.5 mM KCl, 11 mM Glucose, 4 mM CaCl2, and 1 mM MgCl2 that was bubbled with 
95% O2 and 5% CO2. An organoid was visualized using upright microscope BX51WI (Olympus) equipped with 
a 40x water-immersion lens. Recording pipettes with resistances of 3-6 MΩ were filled with internal solution 
containing 135 mM K-gluconate, 10 mM KCl, 10 mM HEPES, 1 mM EGTA, and 2 mM Na2ATP. The pH was 
adjusted to 7.2-7.4 with KOH. Data was acquired using clampex 10.3 software (Molecular devices). Resting 
membrane potentials were measured in a current-clamp configuration with a holding current of 0 pA. Action 
potentials of neurons in organoids were elicited by injecting a series of current steps (0 to 100 pA, with 10 pA 
increments, 200 ms long). Spontaneous postsynaptic currents and single-channel activities were recorded in a 
voltage clamp configuration while holding the membrane potential at -70 mV. 
 
Bioinformatics analysis 
RNA-seq data paired-end files were mapped to the human genome (UCSC, hg38) build using the RNA-seq 
aligner STAR (v2.5.2b). After mapping, the gene expression level was calculated as Fragments Per Kilobase 
Million (FPKM) by Cufflinks, the transcriptome assembly and differential expression analysis tool (v2.2.1), 
based on the default options. To determine clustering in gene expression, statistical analyses were executed with 
the heatmap.2 function (gplots package) in the statistical software R (v3.3.2). Analysis of functional Gene 
Ontology (GO) was performed based on differentially expressed genes by using DAVID (Database for 
Annotation, Visualization and Integrated Discovery, v6.8). In addition, RNA-seq reads mapped by hg38 were 
visualized by the processing tool IGV (Integrative Genomics Viewer). 
 
TUNEL assay 
To observe apoptotic cells in organoids, the TUNEL assay was performed using the in situ cell-death detection 
kit, fluorescein (Roche) according to manufacturer’s protocol. Briefly, the micro-sectioned organoids on glass 
slides were prepared for the TUNEL assay. Samples were permeabilized with permeabilization solution for 2 
min on ice and washed three times with PBS. The samples were then placed in citrate buffer, received 750 W 
microwave irradiation for 1 min, and then were translocated to cool distilled water. Samples were immersed for 
30 min in Tris-HCl (0.1 M, pH 7.5), containing 3% BSA and 20% normal bovine serum at room temperature. 
Then, the TUNEL reaction mixture was added on the tissue section. After the TUNNEL assay, organoid sections 
were blocked and co-stained with antibody raised against TH (Abcam), GABA (Sigma), AQP4 (Merck 
millipore), and PLP1 (Cusabio). 
 
Statistical analysis 
For statistical analysis, the unpaired t-test and ANOVA were used for calculating p values. All the values were 
calculated from at least triplicate experiments and the p values were presented as *P<0.05; **P<0.01; and 
***P<0.001. 
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